Thesis
I just saw West Pharmaceutical's shares drop significantly due to lower-than-expected 2025 guidance, but with the stock being massively oversold (RSI at 11), I think a bounce back is likely. While there are concerns about the life sciences sector, buying here could be a dip opportunity.